eISSN: 2299-0046
ISSN: 1642-395X
Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii
Current issue Archive Manuscripts accepted About the journal Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
2/2021
vol. 38
 
Share:
Share:
abstract:
Original paper

Current practices in diagnosis of Hymenoptera venom allergy in Poland

Ewa Cichocka-Jarosz
1
,
Piotr Brzyski
2
,
Urszula Jedynak-Wąsowicz
1
,
Marita Nittner-Marszalska
3
,
Immunotherapy Section of Polish Society of Allergology Working Group
4

  1. Department of Pediatrics, Jagiellonian University Medical College, Krakow, Poland
  2. “Dziupla” Statistical Analysis Piotr Brzyski, Krakow, Poland
  3. Department of Internal Disease and Allergology, Medical University of Wroclaw, Wroclaw, Poland
  4. 4 Immunotherapy Section of Polish Society of Allergology Working Group: Zbigniew Bajor, Zbigniew Bartuzi, Anna Bodzenta-Łukaszyk, Elżbieta Borucka, Piotr Z. Brewczyński, Anna Bręborowicz, Andrzej Dąbrowski, Radosław Gawlik, Grzegorz Gąszczyk, Marek Jutel, Marek Kowalski, Jerzy Kruszewski, Piotr Kuna, Michał Kurek, Artur Kwaśniewski, Joanna Lange, Teresa Małaczyńska , Elżbieta Matusz, Marek Niedoszytko, Katarzyna Olejniczak, Marek Józef Paśnicki, Jolanta Pietraszek-Mamcarz, Grażyna Pulka, Marta Rachel, Barbara Rogala, Magdalena Rzeszutko-Grabowska, Marcin Stobiecki, Ewa Świebocka, Ewa Trębas-Pietraś, Magdalena Zakrzewska, Aleksander Zakrzewski, Janusz Zaryczański, Małgorzata Żurowska-Gębała
Adv Dermatol Allergol 2021; XXXVIII (2): 222-225
Online publish date: 2021/05/22
View full text Get citation
 
Introduction
Hymenoptera venom allergy (HVA) is associated with a high risk of anaphylaxis. Effective treatment of HVA patients requires allergologists’ familiarity with the latest HVA recommendations.

Aim
Evaluation of current practices in HVA diagnosis in Poland.

Material and methods
A survey questionnaire was conducted in 32 HVA centres in Poland.

Results
The response rate was 97%. There were 1829 patients evaluated due to HVA in 2015. Sixty six percent (n = 21) of the centres used skin prick tests, out which 90% (n = 19) used 100 µg/ml of the venom extract as the highest concentration. All the centres performed intradermal tests (IDT) and serum specific IgE (sIgE), an initial diagnostic tool in 91% (n = 29). The highest venom concentration in IDT was 1 µg/ml in 75% (n = 24), 0.1 µg/ml in 16% (n = 5), 0.01 µg/ml in 3% (n = 1) and 10 µg/ml in 6% (n = 2). Baseline serum tryptase was assessed in 84% of the centres (n = 27), out of which 53% (n = 17) tested all their patients, whereas 31% (n = 10) checked only those with life-threatening reactions. In case of negative IDT/sIgE, 59% of the centres (n = 19) performed components evaluation, while 19% (n = 6) did the basophil activation test. In case of no identification of the culprit insect and sensitization to both venoms, VIT employed venom with higher sIgE.

Conclusions
Most allergology centres in Poland follow HVA guidelines. We identified two inaccuracies in their HVA management including non-adequate venom concentration in IDT and a false belief in correspondence between sIgE concentration and severity of allergic reactions.

keywords:

guidelines, adherence, venom allergy, diagnostics

Quick links
© 2024 Termedia Sp. z o.o.
Developed by Bentus.